- Home
- ADAG vs HLLY Comparison
ADAG vs HLLY Comparison
Compare ADAG & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAG | HLLY |
|---|---|---|
| Founded | 2011 | 1903 |
| Country | China | United States |
| Employees | N/A | 1483 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.3M | 306.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADAG | HLLY |
|---|---|---|
| Price | $3.30 | $2.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $8.25 | $4.83 |
| AVG Volume (30 Days) | 310.1K | ★ 930.5K |
| Earning Date | 04-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $4.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $1.98 |
| 52 Week High | $4.85 | $4.48 |
Technical Indicators
Market Signals| Indicator | ADAG | HLLY |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 52.77 |
| Support Level | $2.78 | $2.41 |
| Resistance Level | $3.53 | $2.63 |
| Average True Range (ATR) | 0.33 | 0.15 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 7.07 | 54.74 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.
About HLLY Holley Inc.
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.